Rotavirus Gastroenteritis in Western Uttar Pradesh, India.


Journal

Indian journal of pediatrics
ISSN: 0973-7693
Titre abrégé: Indian J Pediatr
Pays: India
ID NLM: 0417442

Informations de publication

Date de publication:
03 2021
Historique:
received: 12 11 2020
accepted: 14 12 2020
pubmed: 30 1 2021
medline: 26 5 2021
entrez: 29 1 2021
Statut: ppublish

Résumé

To establish hospital-based surveillance to identify cases of rotavirus (RV) among children < 5 y of age hospitalized for acute gastroenteritis (AGE) and to determine the burden and profile of circulating RV genotypes in the region. This study was conducted at a tertiary level hospital in Bijnor district of western Uttar Pradesh, India from January 2018 to January 2020. The duly filled case reporting forms and specimens of all the enrolled children were transported in cold chain to the referral laboratory at Christian Medical College (CMC), Vellore on a monthly basis for testing and storage of stool samples as well as data entry and analysis. A total of 1055 under-5 children admitted with AGE, were enrolled. Proper stool specimens were collected from 932 children. Rotavirus was found positive in 368 (39.5%) stool specimens. Marked seasonality was observed in RV-positive cases with the highest incidence was noticed during winter months. The 0-11 mo age group had the highest incidence of RV-GE followed by 12-23 mo. G1 (42.08%) was the most frequent G-type whereas G1P[8] (26.23%) was the commonest circulating genotype. The study confirms a significant burden of RV among AGE cases in young children in western Uttar Pradesh. The findings of the study may serve as useful baseline information to the Government of India for assessing vaccine performance after its introduction in the national immunization programmes.

Identifiants

pubmed: 33512672
doi: 10.1007/s12098-020-03623-2
pii: 10.1007/s12098-020-03623-2
doi:

Substances chimiques

Rotavirus Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-65

Références

Troeger C, Blacker BF, Khalil IA, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18:1211–28. Available at: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30362-1/abstract . Accessed 6 Oct 2020.
Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD. Rotavirus vaccines: targeting the developing world. J Infect Dis. 2005;192(Suppl 1):S160–6.
Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1151–210. Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32152-9/abstract . Accessed 6 Oct 2020.
World Health Organization. World health statistics 2018: monitoring health for the SDGs [Internet]. 2018. Available at: http://apps.who.int/iris/bitstream/handle/10665/272596/9789241565585-eng.pdf?ua=1 . Accessed 18 Feb 2019.
Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, World Health Organization–Coordinated Global Rotavirus Surveillance Network. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62(Suppl 2):S96–105.
doi: 10.1093/cid/civ1013
Troeger C, Khalil IA, Rao PC, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172:958–65. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233802/ . Accessed 24 June 2019.
Bányai K, László B, Duque J, et al. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine [Internet]. 2012;30:A122–30. Available at: http://www.sciencedirect.com/science/article/pii/S0264410X11015532 . Accessed 21 Aug 2020.
Babji S, Arumugam R, Sarvanabhavan A, et al. Multi-center surveillance of rotavirus diarrhea in hospitalized children <5 years of age in India, 2009-2012. Vaccine. 2014;32(Suppl 1):A10–2.
Mehendale S, Venkatasubramanian S, Girish Kumar CP, Kang G, Gupte MD, Arora R. Expanded Indian national rotavirus surveillance network in the context of rotavirus vaccine introduction. Indian Pediatr [Internet]. 2016;53:575–81. Available at: http://link.springer.com/10.1007/s13312-016-0891-3 . Accessed 22 Mar 2019.
National Rotavirus Surveillance Network, Kumar CPG, Venkatasubramanian S, Kang G, Arora R, Mehendale S. Profile and trends of rotavirus gastroenteritis in under 5 children in India, 2012–2014, preliminary report of the Indian National Rotavirus Surveillance Network. Indian Pediatr. 2016;53:619–22.
Zachariah KR, Kang G. Rotavirus Vaccines. In: Vashishtha VM, Kalra A, editors. IAP Textbook of Vaccines, 2nd ed. New Delhi: Jaypee Brothers; 2020. p. 323–47.
Vashishtha VM, Thacker S, Namjoshi GS. Immunochromatography-based diagnosis of rotavirus infection in acute diarrhea. Indian Pediatr. 2016;53:652–3.
pubmed: 27508549
Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383:2136–43.
Nair NP, Reddy NS, Giri S, et al. Rotavirus vaccine impact assessment surveillance in India: protocol and methods. BMJ Open [Internet]. 2019;9:e024840. Available at: http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2018-024840 . Accessed 13 Aug 2019.
doi: 10.1136/bmjopen-2018-024840
Malik A, Haldar P, Ray A, et al. Introducing rotavirus vaccine in the universal immunization Programme in India: from evidence to policy to implementation. Vaccine [Internet]. 2019;37:5817–24. Available at: http://www.sciencedirect.com/science/article/pii/S0264410X19310254 . Accessed 15 Sep 2020.
Giri S, Nair NP, Mathew A, et al. Rotavirus gastroenteritis in Indian children < 5 years hospitalized for diarrhoea, 2012 to 2016. BMC Public Health [Internet]. 2019;19:69. Available at: 10.1186/s12889-019-6406-0. Accessed 4 Mar 2019.
doi: 10.1186/s12889-019-6406-0
Kang G, Desai R, Arora R, et al. Diversity of circulating rotavirus strains in children hospitalized with diarrhea in India, 2005-2009. Vaccine. 2013;31:2879–83.
Kahn G, Fitzwater S, Tate J, et al. Epidemiology and prospects for prevention of rotavirus disease in India. Indian Pediatr. 2012;49:467–74.
Kumar A, Basu S, Vashishtha V, Choudhury P. Burden of rotavirus diarrhea in under-five Indian children. Indian Pediatr. 2016;53:607–17. Available at: http://link.springer.com/10.1007/s13312-016-0896-y . Accessed 6 Oct 2020.
doi: 10.1007/s13312-016-0896-y
Saluja T, Sharma SD, Gupta M, et al. A multicenter prospective hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children less than five years of age in India. Vaccine. 2014;32(Suppl 1):A13–9.
Saluja T, Dhingra MS, Sharma SD, et al. Association of rotavirus strains and severity of gastroenteritis in Indian children. Hum Vaccin Immunother. 2017;13:711–6.
Kang G, Arora R, Chitambar SD, et al. Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis. 2009;200(Suppl 1):S147–53.
Banerjee I, Ramani S, Primrose B, et al. Modification of rotavirus multiplex RT-PCR for the detection of G12 strains based on characterization of emerging G12 rotavirus strains from South India. J Med Virol. 2007;79:1413–21. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2465801/ . Accessed 5 Oct 2020.
Das S, Varghese V, Chaudhury S, et al. Emergence of novel human group a rotavirus G12 strains in India. J Clin Microbiol. 2003;41:2760–2. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC156500/ . Accessed 5 Oct 2020.
Rahman M, Matthijnssens J, Yang X, et al. Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol. 2007;81:2382–90.

Auteurs

Vipin M Vashishtha (VM)

Department of Pediatrics, Mangla Hospital & Research Center, Shakti Chowk, Bijnor, Uttar Pradesh, 246701, India. vipinipsita@gmail.com.

Nayana P Nair (NP)

Department of GI Sciences, The Wellcome Trust Research Laboratory, Christian Medical College, Vellore, Tamil Nadu, India.

Mobeen Ahmad (M)

Department of Pediatrics, Mangla Hospital & Research Center, Shakti Chowk, Bijnor, Uttar Pradesh, 246701, India.

Ipsita Vashishtha (I)

Department of Pediatrics, Mangla Hospital & Research Center, Shakti Chowk, Bijnor, Uttar Pradesh, 246701, India.

Varunkumar Thiyagarajan (V)

Department of GI Sciences, The Wellcome Trust Research Laboratory, Christian Medical College, Vellore, Tamil Nadu, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH